FDA says Biovail pain drug Tramadol will need new clinical trials before approval

TORONTO (CP) - Drugmaker Biovail Corp.'s pain treating drug Tramadol ER will require yet another round of clinical trials before it can be approved for release in the United States, the company said Wednesday.

Toronto-based Biovail said the U.S....More